State Street’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.2M | Buy |
|
|||||
|
2025
Q1 | $76.4M | Sell |
|
|||||
|
2024
Q4 | $79.7M | Buy |
|
|||||
|
2024
Q3 | $70.8M | Buy |
|
|||||
|
2024
Q2 | $58M | Buy |
|
|||||
|
2024
Q1 | $49.1M | Buy |
|
|||||
|
2023
Q4 | $47.7M | Buy |
|
|||||
|
2023
Q3 | $37.3M | Buy |
|
|||||
|
2023
Q2 | $44.2M | Sell |
|
|||||
|
2023
Q1 | $47.5M | Sell |
|
|||||
|
2022
Q4 | $43.4M | Sell |
|
|||||
|
2022
Q3 | $81.9M | Sell |
|
|||||
|
2022
Q2 | $96.7M | Sell |
|
|||||
|
2022
Q1 | $123M | Buy |
|
|||||
|
2021
Q4 | $137M | Sell |
|
|||||
|
2021
Q3 | $128M | Buy |
|
|||||
|
2021
Q2 | $113M | Buy |
|
|||||
|
2021
Q1 | $119M | Sell |
|
|||||
|
2020
Q4 | $116M | Buy |
|
|||||
|
2020
Q3 | $92.6M | Sell |
|
|||||
|
2020
Q2 | $113M | Sell |
|
|||||
|
2020
Q1 | $91.1M | Sell |
|
|||||
|
2019
Q4 | $131M | Sell |
|
|||||
|
2019
Q3 | $126M | Buy |
|
|||||
|
2019
Q2 | $134M | Sell |
|
|||||
|
2019
Q1 | $162M | Buy |
|
|||||
|
2018
Q4 | $136M | Buy |
|
|||||
|
2018
Q3 | $236M | Sell |
|
|||||
|
2018
Q2 | $189M | Sell |
|
|||||
|
2018
Q1 | $157M | Sell |
|
|||||
|
2017
Q4 | $132M | Buy |
|
|||||
|
2017
Q3 | $116M | Buy |
|
|||||
|
2017
Q2 | $98.5M | Sell |
|
|||||
|
2017
Q1 | $90M | Buy |
|
|||||
|
2016
Q4 | $86.3M | Sell |
|
|||||
|
2016
Q3 | $88.9M | Buy |
|
|||||
|
2016
Q2 | $87.9M | Buy |
|
|||||
|
2016
Q1 | $74.9M | Buy |
|
|||||
|
2015
Q4 | $68.9M | Buy |
|
|||||
|
2015
Q3 | $50.6M | Sell |
|
|||||
|
2015
Q2 | $61M | Sell |
|
|||||
|
2015
Q1 | $49.9M | Sell |
|
|||||
|
2014
Q4 | $35.6M | Buy |
|
|||||
|
2014
Q3 | $30.4M | Buy |
|
|||||
|
2014
Q2 | $35.6M | Sell |
|
|||||
|
2014
Q1 | $39.6M | Sell |
|
|||||
|
2013
Q4 | $33.1M | Sell |
|
|||||
|
2013
Q3 | $33M | Buy |
|
|||||
|
2013
Q2 | $19.1M | Buy |
|